‘Diagnostics’ refers to the diagnosis and management of patients who are referred for assessment, most commonly because of a raised PSA (prostate specific antigen) blood test. It is important to assess each patient and make sure those who do not have prostate cancer leave with their presenting symptoms treated. For those who are found to have underlying prostate cancer, a full evaluation takes place of both their cancer and them as a person so that the best treatment for them is proposed.
A robotic assisted radical prostatectomy (RARP) is the operation of choice for a man needing surgery for prostate cancer. Mr Cahill is a leading expert in this operation. More information about the operation and Mr Cahill’s outcomes can found by clicking on the link below:
Once a diagnosis of prostate cancer has been made then the next step is to agree with the patient the best management. Half of newly diagnosed cancers will be slow-growing and it is likely that the cancer will not impact or shorten their life. These patients can be offered ‘active surveillance’. They are monitored and re-assessed. If monitoring spots change they can switch to curative treatment.
PATIENT DIAGNOSTICS
‘Diagnostics’ refers to the diagnosis and management of patients who are referred for assessment, most commonly because of a raised PSA (prostate specific antigen) blood test. It is important to assess each patient and make sure those who do not have prostate cancer leave with their presenting symptoms treated. For those who are found to have underlying prostate cancer, a full evaluation takes place of both their cancer and them as a person so that the best treatment for them is proposed.
ROBOTIC ASSISTED RADICAL PROSTATECTOMY
A robotic assisted radical prostatectomy (RARP) is the operation of choice for a man needing surgery for prostate cancer. Mr Cahill is a leading expert in this operation. More information about the operation and Mr Cahill’s outcomes can found by clicking on the link below:
ACTIVE SURVEILLANCE
Once a diagnosis of prostate cancer has been made then the next step is to agree with the patient the best management. Half of newly diagnosed cancers will be slow-growing and it is likely that the cancer will not impact or shorten their life. These patients can be offered ‘active surveillance’. They are monitored and re-assessed. If monitoring spots change they can switch to curative treatment.